APA

Bohnert B. N., Daiminger S., Wörn M., Sure F., Staudner T., Ilyaskin A. V., Batbouta F., Janessa A., Schneider J. C., Essigke D., Kanse S., Haerteis S., Korbmacher C. & Artunc F. (20200922). Urokinase-type plasminogen activator (uPA) is not essential for epithelial sodium channel (ENaC)-mediated sodium retention in experimental nephrotic syndrome. : Acta physiologica (Oxford, England).

Chicago

Bohnert Bernhard N, Daiminger Sophie, Wörn Matthias, Sure Florian, Staudner Tobias, Ilyaskin Alexandr V, Batbouta Firas, Janessa Andrea, Schneider Jonas C, Essigke Daniel, Kanse Sandip, Haerteis Silke, Korbmacher Christoph and Artunc Ferruh. 20200922. Urokinase-type plasminogen activator (uPA) is not essential for epithelial sodium channel (ENaC)-mediated sodium retention in experimental nephrotic syndrome. : Acta physiologica (Oxford, England).

Harvard

Bohnert B. N., Daiminger S., Wörn M., Sure F., Staudner T., Ilyaskin A. V., Batbouta F., Janessa A., Schneider J. C., Essigke D., Kanse S., Haerteis S., Korbmacher C. and Artunc F. (20200922). Urokinase-type plasminogen activator (uPA) is not essential for epithelial sodium channel (ENaC)-mediated sodium retention in experimental nephrotic syndrome. : Acta physiologica (Oxford, England).

MLA

Bohnert Bernhard N, Daiminger Sophie, Wörn Matthias, Sure Florian, Staudner Tobias, Ilyaskin Alexandr V, Batbouta Firas, Janessa Andrea, Schneider Jonas C, Essigke Daniel, Kanse Sandip, Haerteis Silke, Korbmacher Christoph and Artunc Ferruh. Urokinase-type plasminogen activator (uPA) is not essential for epithelial sodium channel (ENaC)-mediated sodium retention in experimental nephrotic syndrome. : Acta physiologica (Oxford, England). 20200922.